证券研究报告·公司点评报告·半导体 中微公司（688012） 2024 年报点评：营收快速增长，平台化布局 加速 买入（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 6,264 | 9,065 | 11,472 | 14,179 | 17,540 | | 同比（%） | 32.15 | 44.73 | 26.55 | 23.60 | 23.70 | | 归母净利润（百万元） | 1,786 | 1,616 | 2,432 | 3,402 | 4,454 | | 同比（%） | 52.67 | (9.53) | 50.53 | 39.89 | 30.92 | | EPS-最新摊薄（元/股） | 2.87 | 2.60 | 3.91 | 5.47 | 7.16 | | P/E（现价&最新摊薄） | 66.74 | 73.77 | 49.00 | 35.03 | 26.76 | [Table_Tag] [投资要点 Tabl ...

证券研究报告·公司点评报告·半导体 [Table_Tag] [投资要点 Table_Summary] 2025 年 04 月 18 日 证券分析师 周尔双 执业证书：S0600515110002 021-60199784 zhouersh@dwzq.com.cn 证券分析师 李文意 中微公司（688012） 2024 年报点评：营收快速增长，平台化布局 加速 买入（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 6,264 | 9,065 | 11,472 | 14,179 | 17,540 | | 同比（%） | 32.15 | 44.73 | 26.55 | 23.60 | 23.70 | | 归母净利润（百万元） | 1,786 | 1,616 | 2,432 | 3,402 | 4,454 | | 同比（%） | 52.67 | (9.53) | 50.53 | 39.89 | 30.92 | | EPS-最新 ...

证券研究报告 | 年报点评报告 gszqdatemark 2025 04 18 年 月 日 中微公司（688012.SH） 营收持续高增，设备平台化布局渐丰 中微公司发布 2024 年年报。2024 年公司实现营收 90.65 亿元，yoy+44.7%，实现归母净 利润 16.16 亿元，yoy-9.5%，实现扣非后归母净利润 13.88 亿元，yoy+16.5%，实现毛利 率 41.06%，净利率 17.8%。公司 2024 年研发投入达 24.52 亿元，yoy+94.31%，相较于 2023 年增长 11.9 亿元。单季度来看，公司 24Q4 实现营收 35.58 亿元，yoy+60.11%， qoq+72.76%，实现归母净利润7.03亿元，yoy+12.24%，qoq+77.32%，实现毛利率39.26%， 实现净利率 19.73%。公司 2024 年人均销售超 400 万元，达到设备产业国际先进水平。 刻蚀设备装机量高增，市占率持续提升。2024 年公司刻蚀设备实现营收 72.77 亿元，同比 增长 54.72%，近四年收入年均增长超 50%。公司刻蚀设备可覆盖 95%以上的刻蚀应用需 求。分产品 ...

Investment Rating - The report maintains a "Buy" rating for the company [5] Core Views - The company achieved a revenue of 9.065 billion yuan in 2024, representing a year-over-year increase of 44.7%, while the net profit attributable to shareholders was 1.616 billion yuan, down 9.5% year-over-year [1] - The company has significantly increased its R&D investment to 2.452 billion yuan in 2024, a year-over-year growth of 94.31% [1] - The company is expanding its equipment platform, particularly in etching and MOCVD devices, which are seeing substantial revenue growth and market share increases [2][3] Summary by Sections Financial Performance - In 2024, the company reported a revenue of 9.065 billion yuan, with a gross margin of 41.06% and a net margin of 17.8% [1] - The fourth quarter of 2024 saw a revenue of 3.558 billion yuan, a year-over-year increase of 60.11% [1] - The company forecasts revenues of 12.074 billion yuan, 15.801 billion yuan, and 20.542 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 2.552 billion yuan, 3.560 billion yuan, and 4.850 billion yuan [3][4] Product Development - The etching equipment segment generated 7.277 billion yuan in revenue in 2024, growing 54.72% year-over-year [2] - The MOCVD equipment segment achieved 379 million yuan in revenue, maintaining a leading position in the international market for GaN-based MOCVD equipment [2] - The company has launched its first LPCVD equipment sales, generating approximately 156 million yuan in revenue, with a total of 4.76 billion yuan in bulk orders for 2024 [2] Employee Incentives - The company plans to implement a new stock incentive plan, granting up to 12 million restricted shares to motivate employees and align their interests with the company's long-term growth [3]

Investment Rating - The investment rating for the company is "Buy-A" with a target price of 234.27 CNY per share, maintaining the rating [5][10]. Core Views - The company achieved a revenue of 9.065 billion CNY in 2024, representing a year-on-year increase of 44.73%, driven by breakthroughs in mass production of new equipment such as LPCVD and ALD [1]. - The net profit attributable to shareholders decreased by 9.53% year-on-year to 1.616 billion CNY, primarily due to increased R&D investment and the absence of a one-time gain from the sale of stocks in the previous year [1][10]. - The company is expected to continue its strong revenue growth, with projected revenues of 11.771 billion CNY, 15.262 billion CNY, and 18.680 billion CNY for 2025, 2026, and 2027 respectively [10]. Financial Performance - In Q4 2024, the company reported a revenue of 3.558 billion CNY, up 60.11% year-on-year, and a net profit of 703 million CNY, an increase of 12.24% year-on-year [1]. - The overall gross margin for 2024 was 41.06%, a decrease of 2.75 percentage points year-on-year, with specific margins for specialized equipment, spare parts, and other products at 39.80%, 48.18%, and 58.30% respectively [2]. - The company’s R&D expenses increased by 94.31% year-on-year, reflecting its commitment to innovation and platform development [2]. Market Position and Product Development - The company’s etching equipment sales reached approximately 7.277 billion CNY in 2024, marking a year-on-year increase of 54.72% [3]. - The company has successfully developed and received orders for six types of LPCVD equipment, with total sales of approximately 1.56 billion CNY in 2024 [9]. - A new semiconductor equipment production base is planned in Chengdu with an investment of 30.5 billion CNY, expected to start construction in 2025 and achieve annual sales of 1 billion CNY by 2030 [9]. Future Projections - The company is projected to achieve net profits of 2.430 billion CNY, 3.402 billion CNY, and 4.541 billion CNY for 2025, 2026, and 2027 respectively [10]. - The company is positioned to benefit from the domestic substitution trend in the semiconductor industry, which is expected to enhance its market share [10].

Core Viewpoint - In 2024, the company achieved a revenue of approximately 9.065 billion yuan, marking a year-on-year growth of about 44.73%, while net profit attributable to shareholders decreased by 9.53% to 1.616 billion yuan [1][2] Revenue and Profit Summary - The company's revenue surpassed 9 billion yuan for the first time, with a notable increase in revenue from etching equipment, which reached approximately 7.277 billion yuan, reflecting a year-on-year growth of about 54.73% [1][2] - The net profit decline is attributed to increased R&D investments aimed at addressing the domestic high-end semiconductor equipment gap, with R&D expenditure reaching approximately 2.452 billion yuan, a year-on-year increase of about 94.31% [2][3] R&D and Product Development - The company significantly increased its R&D investment, which accounted for approximately 27.05% of its revenue in 2024, far exceeding the average of the Sci-Tech Innovation Board [2][3] - The company is developing over twenty new devices across six categories, with a reduced development cycle of two years or less for competitive new products [3] Market Position and Future Outlook - The company’s CCP and ICP etching equipment cover over 95% of domestic etching application needs and have achieved mass production in advanced 5nm process lines [2] - The global semiconductor industry is experiencing a new wave of development opportunities, with a projected market size of $127.5 billion by 2025, driven by advancements in AI, cloud computing, and autonomous driving [5]

Core Viewpoint - In 2024, Zhongwei Company achieved a revenue of 9.065 billion yuan, marking a year-on-year growth of 44.7%, with etching equipment contributing over 7.2 billion yuan, while net profit decreased by 9.5% due to increased R&D investment [1] Group 1: Financial Performance - Revenue for 2024 reached 9.065 billion yuan, a 44.7% increase year-on-year [1] - Etching equipment sales exceeded 7.2 billion yuan, growing by 54.7% [1] - Net profit was approximately 1.616 billion yuan, down 9.5% year-on-year, primarily due to a significant rise in R&D expenses [1] - R&D expenses amounted to 2.45 billion yuan, reflecting a 94.3% increase [1] - Non-GAAP net profit was about 1.388 billion yuan, showing a growth of 16.5% [1] Group 2: Operational Highlights - In 2024, the average sales per employee surpassed 4 million yuan, compared to 3.5 million yuan in 2022 [2] - The company shipped over 1,200 CCP etching equipment units, setting a historical record, with cumulative installations exceeding 4,000 units [2] - The average compound annual growth rate for the past ten years has been over 30% [2] - Nearly 60 CCP dual-station machines are in mass production on the most advanced logic production lines, including those at 5nm and beyond [2] - The LPCVD equipment has seen over 150 units shipped after market validation, with bulk orders worth approximately 476 million yuan in 2024 [2] Group 3: Strategic Developments - Zhongwei Company announced plans to increase capital in Ultra Micro Semiconductor Equipment (Shanghai) Co., Ltd., raising its registered capital to 160 million yuan, with Zhongwei contributing 75.5 million yuan for a 47.2% stake [2] - Ultra Micro Company, established in 2024, will focus on developing electron beam measurement equipment [2] - The measurement equipment market is rapidly growing, accounting for about 13% of the total semiconductor front-end equipment market [3] - The company aims to expand its market participation and coverage in various types of measurement equipment [3]

4月17日晚间，中微公司(688012)发布2024年年度报告。报告显示，凭借核心技术突破、研发高强度投 入及运营效率优化，中微公司2024年实现营业收入约90.65亿元，同比增长约44.73%，保持了近四年营 收年均增幅大于40%；扣除非经常性损益的净利润约13.88亿元，同比增长约16.52%。 从行业情况来看，近年来随着人工智能、云计算、大数据、自动驾驶等数码技术相关的产业进一步加速 发展，半导体微观制造设备作为数码产业的基石，其市场高速发展。据国际半导体产业协会(SEMI)数 据，全球半导体设备市场规模由2019年的576亿美元提升至2023年的1063亿美元，年均复合增长率达到 16.55%。2024年，全球半导体设备市场规模1171亿美元，同比增长10.16%；其中，中国大陆半导体设 备市场规模达到496亿美元，同比增长35%，占全球总规模的44%。 "工欲善其事，必先利其器。"在研发方面，2024年，公司研发投入达24.5亿元，同比增长94.3%，占营 业收入比例约27%。高强度的研发投入推动产品迭代速度显著提升——过去开发一款新设备需3至5年， 如今仅需2年甚至更短时间即可完成。 年报显示，目 ...

中微半导体设备(上海)股份有限公司 2024 年度内部控制审计报告 . . . 普华永道 中微半导体设备(上海)股份有限公司全体股东; 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我 们审计了中微半导体设备(上海)股份有限公司(以下简称"中微公司")2024年12 月31日的财务报告内部控制的有效性。 一、 企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部 控制评价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是中微 公司董事会的责任。 二、 注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表 审计意见,并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、 内部控制的固有局限性 内部控制具有固有局限性,存在不能防止和发现错报的可能性。此外,由于 情况的变化可能导致内部控制变得不恰当,或对控制政策和程序遵循的程度降 低,根据内部控制审计结果推测未来内部控制的有效性具有一定风险。 内部控制审计报告 普华永道中天特审字(2025)第 0142 号 (第一页,共二页) 张 炜 彬 普华永道中天会计师事务所(特殊 ...

证券代码：688012 证券简称：中微公司 公告编号：2025-014 中微半导体设备（上海）股份有限公司 关于预计 2025 年年度日常关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 是否需要提交股东大会审议：是 日常关联交易对上市公司的影响：本次关联交易属公司日常关联交易， 是正常生产经营业务，以市场价格为定价依据，遵循平等自愿原则，交易风险 可控，不存在损害公司及股东利益的情况，不会对关联人形成较大的依赖。 一、日常关联交易基本情况 （一）日常关联交易履行的审议程序 中微半导体设备（上海）股份有限公司（以下简称"公司"）于 2025 年 4 月 17 日召开第三届董事会第二次会议，审议通过《关于预计 2025 年年度日常关联 交易的议案》，关联董事尹志尧、杨卓、朱民回避了表决，此议案获出席会议的 非关联董事一致表决通过。 公司董事会审计委员会已就该事项发表了书面审核意见：公司 2025 年年度 预计发生的日常关联交易是公司按照公平、公正、公开原则开展，不会损害公司 和全体股东的利益，审 ...